Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993

Nerve pathology and neuropathic pain after whiplash injury: a systematic review and meta-analysis

Fundaun J. et al, (2021), Pain

[Entrapment neuropathies: a contemporary approach to pathophysiology, clinical assessment, and management : German version].

Schmid AB. et al, (2021), Schmerz

Systemic inflammatory markers in neuropathic pain, nerve injury and recovery.

Sandy-Hindmarch O. et al, (2021), Pain

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2021), Nat Med

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2021), Nat Med

Erratum: Molecular and cellular correlates of human nerve regeneration: ADCYAP1/PACAP enhance nerve outgrowth (Brain (2020) 143 (2009-2026) DOI: 10.1093/brain/awaa163)

Baskozos G. et al, (2021), Brain, 144

Sensorimotor and body perception assessments of nonspecific chronic low back pain: a cross-sectional study

Meier R. et al, (2021), BMC Musculoskeletal Disorders

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Voysey M. et al, (2021), Lancet, 397, 881 - 891

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Ewer KJ. et al, (2021), Nat Med, 27, 270 - 278

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Barrett JR. et al, (2020), Nat Med

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Voysey M. et al, (2020), Lancet

Occupational Therapists, Physiotherapists and Orthopaedic Surgeons Agree on the Decision for Carpal Tunnel Surgery

Lewis K. et al, (2020), International Journal of Health Policy and Management

Somatosensory and psychological phenotypes associated with neuropathic pain in entrapment neuropathy.

Matesanz L. et al, (2020), Pain

Somatosensory profiles in patients with non-specific neck-arm pain with and without positive neurodynamic tests.

Ottiger-Boettger K. et al, (2020), Musculoskelet Sci Pract, 50

Molecular and cellular correlates of human nerve regeneration: ADCYAP1/PACAP enhance nerve outgrowth.

Baskozos G. et al, (2020), Brain, 143, 2009 - 2026

Group education, night splinting and home exercises reduce conversion to surgery for carpal tunnel syndrome: a multicentre randomised trial.

Lewis KJ. et al, (2020), J Physiother, 66, 97 - 104

Small Fibre Pathology in Chronic Whiplash-Associated Disorder: A Cross-Sectional Study.

Farrell SF. et al, (2020), Eur J Pain

Neurodynamik – Was wissen wir heute?

Tampin B. and Schmid A., (2020), manuelletherapie, 24, 9 - 14

Novel Genetic Evidence That Increased Body Mass Index Has a Causal Role in the Development of Carpal Tunnel Syndrome

Smillie R. et al, (2019), BRITISH JOURNAL OF SURGERY, 106, 5 - 5

Load More

Include forthcoming?